|
Home Automatic External Defibrillator Trial -- HAT Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Home Automatic External Defibrillator Trial -- HAT conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Home Automatic External Defibrillator Trial -- HAT Clinical research trials and Home Automatic External Defibrillator Trial -- HAT medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Home Automatic External Defibrillator Trial -- HAT. Home Automatic External Defibrillator Trial -- HAT Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Home Automatic External Defibrillator Trial -- HAT clinical trial. Participants frequently obtain the most expert healthcare available for their Home Automatic External Defibrillator Trial -- HAT condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "H" Clinical Trials Conditions > Home Automatic External Defibrillator Trial -- HAT  Home Automatic External Defibrillator Trial -- HAT
Home Automatic External Defibrillator Trial -- HAT
For Condition: Death, Sudden, Cardiac,Cardiovascular Diseases,Myocardial Infarction,Heart Diseases
Status: Recruiting
Sponsor(s): National Heart, Lung, and Blood Institute (NHLBI) ,
Synopsis: To compare home use of an automatic external defibrillator to the local emergency medical system in survivors of a heart attack.
Details: BACKGROUND: Sudden cardiac arrest (SCA) occurs every 2 minutes throughout the US; most, more than 70 percent, occur at home. Because survival falls 10 percent per minute over the first 10 minutes, it is imperative to defibrillate as close to time zero as possible. Public efforts cannot provide defibrillation fast enough in most cases. The investigators believe the initial shock is best done by the family only seconds from their loved one using readily available automatic external defibrillators (AEDs). DESIGN NARRATIVE: The trial tests the central hypothesis that provision of an AED for home use will improve survival beyond that achieved from the typical lay response to sudden cardiac arrest. An estimated 7,000 patients will be randomized following anterior myocardial infarction (MI) either to standard lay response to sudden cardiac arrest (call emergency medical service (EMS) systems/CPR) or to add the use of a home AED to the standard response. The standard response will be augmented and standardized by the provision of a video on how to respond to sudden cardiac arrest and how to perform CPR. The goal for the standard response is immediate notification of EMS and prompt CPR. The goal for AED is to shock twice immediately, if indicated by the AED, and call EMS and perform CPR as soon as possible and preferably within two minutes of collapse. Patients will be enrolled for more than two years and followed for an additional two years. Treatment arms will be compared using an intention-to-treat analysis. The primary endpoint is all-cause mortality in the two arms of the trial. Secondary endpoints include survival in the two arms of the study free from post-arrest neurological impairments and the quality of life of the patients and their spouses. The study will be performed at 200 cardiology clinics.
Eligibility:
Study Type: Interventional, Prevention, Randomized
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: A history of anterior myocardial infarction. Live-in spouse-companion willing to administer CPR or AED therapy plus CPR as indicated. No existing implantable cardiac defibrillator or automatic external defibrillator. Cannot be a current candidate for an implantable cardiac defibrillator. Cannot have current "Do Not Resuscitate" orders.
Total Enrollment:
Location and Contact Information:
Seattle Institute for Cardiac Research *Recruiting*
Seattle, Washington, 98103
United States
Recruiting HAT Center 866-500-4428
Additional Information:
Study ID Numbers: 147;
Study Start Date: September 2002
Record last reviewed: February 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00047411
Other Cardiovascular Diseases Studies:
1. Genetics of the Metabolic Syndrome in Japanese Americans
2. Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
3. Dietary Intervention Study for Hypertension (DISH)
4. Modeling DNA Diversity in Cardiovascular Health/Disease
5. CVD Nutrition Education for Low Literacy ESL Students
Related Studies:
Other Cardiovascular Diseases Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials
Home Automatic External Defibrillator Trial -- HAT
|
|
|
|
|
|
|
|
